
CRH Medical Corporation CRHM
Country |
|
IPO year |
2015 |
Industry |
Medical instruments |
Stock Exchange |
NYSE AMERICAN |
Shares |
71.5 M |
Market Cap[1] |
$ 282 M |
EBITDA (LTM) |
$ -6.25 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Ekso Bionics Holdings
EKSO
|
$ 11.8 | 1.29 % | $ 28.6 M | Nasdaq Capital Market | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
iRhythm Technologies
IRTC
|
$ 117.47 | -1.43 % | $ 3.76 B | Nasdaq Global Select Market,SPB | ||
|
Alcon
ALC
|
$ 74.39 | 1.24 % | $ 40.4 B | NYSE | ||
|
Intuitive Surgical
ISRG
|
$ 455.19 | 0.63 % | $ 162 B | Nasdaq Global Select Market,SPB | ||
|
Repro Med Systems
KRMD
|
$ 4.06 | 1.75 % | $ 188 M | Nasdaq Capital Market | ||
|
The Cooper Companies
COO
|
$ 61.49 | -0.13 % | $ 12.2 B | NYSE,SPB | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Envista Holdings Corporation
NVST
|
$ 26.09 | 1.08 % | $ 4.38 B | NYSE | ||
|
Masimo Corporation
MASI
|
$ 178.31 | 0.06 % | $ 9.5 B | Nasdaq Global Select Market,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 19.3 | -3.64 % | $ 1.3 B | Nasdaq Global Select Market | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
electroCore
ECOR
|
$ 6.7 | 0.3 % | $ 56.8 K | Nasdaq Global Select Market | ||
|
STERIS plc
STE
|
$ 212.91 | 0.31 % | $ 21 B | NYSE,SPB | ||
|
STAAR Surgical Company
STAA
|
$ 27.38 | 0.32 % | $ 1.36 B | Nasdaq Global Market,SPB | ||
|
Haemonetics Corporation
HAE
|
$ 55.6 | 0.51 % | $ 2.8 B | NYSE,SPB | ||
|
Teleflex Incorporated
TFX
|
$ 119.89 | - | $ 5.35 B | NYSE,SPB | ||
|
ICU Medical
ICUI
|
$ 117.72 | -0.8 % | $ 2.9 B | Nasdaq Global Select Market,SPB | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
Glaukos Corporation
GKOS
|
$ 134.46 | -1.02 % | $ 6.51 B | NYSE,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 10.6 | 2.02 % | $ 219 M | NYSE American | ||
|
Microbot Medical
MBOT
|
$ 2.13 | 0.95 % | $ 97.5 M | Nasdaq Global Select Market | ||
|
Utah Medical Products
UTMD
|
$ 65.28 | 0.97 % | $ 212 M | Nasdaq Global Select Market | ||
|
Milestone Scientific
MLSS
|
$ 0.38 | 5.66 % | $ 31.2 M | NYSE American | ||
|
Merit Medical Systems
MMSI
|
$ 61.01 | -1.61 % | $ 3.61 B | Nasdaq Global Select Market,SPB | ||
|
West Pharmaceutical Services
WST
|
$ 306.27 | 1.94 % | $ 22.1 B | NYSE,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 11.05 | -0.94 % | $ 2.2 B | Nasdaq Global Select Market,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.66 | 1.75 % | $ 19.8 M | NYSE American | ||
|
Pro-Dex
PDEX
|
$ 54.71 | 6.79 % | $ 180 M | Nasdaq Global Select Market | ||
|
LeMaitre Vascular
LMAT
|
$ 112.46 | 0.83 % | $ 2.55 B | Nasdaq Global Market,SPB | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
BioLife Solutions
BLFS
|
$ 21.17 | 0.38 % | $ 975 M | Nasdaq Global Select Market | ||
|
Stereotaxis
STXS
|
$ 1.95 | 2.37 % | $ 177 M | NYSE American | ||
|
Baxter International
BAX
|
$ 16.88 | 1.53 % | $ 8.66 B | NYSE,SPB | ||
|
ResMed
RMD
|
$ 207.27 | -1.03 % | $ 30.3 B | NYSE,SPB | ||
|
AtriCure
ATRC
|
$ 28.68 | -0.36 % | $ 1.37 B | Nasdaq Global Market,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 6.59 | 2.97 % | $ 293 M | Nasdaq Global Market | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
AngioDynamics
ANGO
|
$ 11.11 | 1.18 % | $ 454 M | Nasdaq Global Select Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 145.15 | -0.79 % | $ 41.8 B | NYSE,SPB | ||
|
Nephros
NEPH
|
$ 3.15 | 2.79 % | $ 32.7 M | Nasdaq Global Select Market | ||
|
OraSure Technologies
OSUR
|
$ 3.02 | 2.37 % | $ 222 M | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 126.41 | 6.94 % | $ 7.04 M | Nasdaq Global Select Market,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.